Substance Use Trends and Implications for Pain Assessments

This session will examine current regulation and use patterns of pain-relieving substances including kratom, nitrous oxide, kava and nitazines. Because these substances are increasingly accessible and may not be detected via urine drug screenings, we will equip health care professionals with strategies for undisclosed use among people with pain and the general public.

Learn more and Register

This is a series of livestreamed webinars and on-demand online courses to meet the need for current pain management education that focuses on integrative evidence-based approaches and risk reduction for person-centered care. Both pharmacologic and non-pharmacologic approaches will be highlighted with experts representing a variety of health and therapeutic professions.

1. Understand current use of pain-relieving substances including kratom, nitrous oxide, kava and nitazines.
2. Recognize signs and symptoms of unreported substance use.
3. Identify reliable patient education and treatment resources for people who are taking unprescribed substances.

The Washington State University (WSU) Elson S. Floyd College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The WSU Elson S. Floyd College of Medicine designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Participants should claim only the credit commensurate with the extent of their participation in the activity.

The Washington State University College of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacy continuing education credits (1.00 contact hour(s), knowledge-based, ACPE Activity Number: 0071-0000-26-018-L08-P/T are available for this activity.

Washington State University College of Nursing is approved as a provider of nursing continuing professional development by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is eligible for {CME Hours} contact hours.

Accessibility

WSU College of Medicine Continuing Medical Education (CME) is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Act of 2008. If you have needs that require accommodation please contact the CME Unit at [email protected]

WSU Notice of Nondiscrimination

Please visit the Office of Compliance and Civil Rights to view Washington State University's policies.

WSU Institutional Neutrality

At Washington State University, we are committed to fostering an environment where diverse ideas and perspectives can flourish. As such, the university will maintain a practice of neutrality and will not take a position on contentious political or social issues, except in rare circumstances. Please visit WSU's Office of the President for more information.

Disclaimer

The material presented in this continuing medical education program is being made available for educational purposes only. This material is not intended to represent the best or only methods or procedures appropriate for the medical situation discussed; rather the material is intended to present an approach, view, statement, or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. This program does not represent or speak on behalf of Washington State University and/ or Elson S. Floyd College of Medicine. Participants should carefully consider all available scientific data before acting on knowledge gained through this activity.

Mitigation of Relevant Financial Relationships

Washington State University Elson S. Floyd College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies within the past 24 months. This information is listed below. All relevant financial relationships, if applicable, have been mitigated. No others in control of content had any relevant financial relationships. If the topic is non-clinical, financial disclosures are not required. 

Friday, November 13, 2026